Eminence Capital LP Has $122.01 Million Holdings in Tenet Healthcare Corporation $THC

Eminence Capital LP reduced its position in Tenet Healthcare Corporation (NYSE:THC) by 44.7% during the 4th quarter, HoldingsChannel.com reports. The firm owned 613,961 shares of the company’s stock after selling 495,489 shares during the quarter. Tenet Healthcare makes up about 1.9% of Eminence Capital LP’s investment portfolio, making the stock its 22nd largest holding. Eminence Capital LP’s holdings in Tenet Healthcare were worth $122,006,000 at the end of the most recent reporting period.

Several other hedge funds also recently bought and sold shares of THC. NewEdge Advisors LLC increased its position in Tenet Healthcare by 6.1% in the 1st quarter. NewEdge Advisors LLC now owns 2,890 shares of the company’s stock worth $389,000 after purchasing an additional 166 shares during the last quarter. Jones Financial Companies Lllp increased its holdings in shares of Tenet Healthcare by 299.1% during the 1st quarter. Jones Financial Companies Lllp now owns 1,700 shares of the company’s stock valued at $229,000 after acquiring an additional 1,274 shares during the last quarter. Sivia Capital Partners LLC acquired a new position in shares of Tenet Healthcare during the 2nd quarter valued at about $290,000. Quantbot Technologies LP acquired a new position in shares of Tenet Healthcare during the 2nd quarter valued at about $65,000. Finally, Amundi boosted its stake in Tenet Healthcare by 4,207.8% during the 2nd quarter. Amundi now owns 27,010 shares of the company’s stock valued at $4,652,000 after purchasing an additional 26,383 shares during the period. 95.44% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on THC shares. Mizuho raised their price target on shares of Tenet Healthcare from $235.00 to $265.00 and gave the stock an “outperform” rating in a research report on Thursday, March 12th. Wells Fargo & Company decreased their price objective on Tenet Healthcare from $265.00 to $213.00 and set an “overweight” rating on the stock in a report on Friday, May 1st. Guggenheim decreased their price objective on Tenet Healthcare from $283.00 to $252.00 and set a “buy” rating on the stock in a report on Friday, May 1st. Stephens decreased their price objective on Tenet Healthcare from $275.00 to $260.00 and set an “overweight” rating on the stock in a report on Monday, May 4th. Finally, KeyCorp cut their target price on Tenet Healthcare from $250.00 to $225.00 and set an “overweight” rating for the company in a research report on Friday, May 1st. Eighteen research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat.com, Tenet Healthcare currently has an average rating of “Moderate Buy” and a consensus price target of $244.16.

Insider Buying and Selling at Tenet Healthcare

In other Tenet Healthcare news, Director J Robert Kerrey sold 5,638 shares of Tenet Healthcare stock in a transaction on Thursday, May 28th. The stock was sold at an average price of $174.52, for a total value of $983,943.76. Following the completion of the transaction, the director owned 16,804 shares in the company, valued at approximately $2,932,634.08. The trade was a 25.12% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Nadja West sold 3,000 shares of Tenet Healthcare stock in a transaction on Wednesday, May 27th. The shares were sold at an average price of $177.35, for a total value of $532,050.00. Following the completion of the transaction, the director owned 24,805 shares of the company’s stock, valued at approximately $4,399,166.75. The trade was a 10.79% decrease in their position. The SEC filing for this sale provides additional information. Insiders own 0.97% of the company’s stock.

Tenet Healthcare Price Performance

Tenet Healthcare stock opened at $178.63 on Thursday. The company has a debt-to-equity ratio of 1.96, a current ratio of 1.36 and a quick ratio of 1.30. The company has a market capitalization of $15.39 billion, a PE ratio of 9.29, a price-to-earnings-growth ratio of 1.51 and a beta of 1.28. Tenet Healthcare Corporation has a one year low of $146.60 and a one year high of $247.21. The business has a 50 day simple moving average of $183.44 and a 200 day simple moving average of $199.04.

Tenet Healthcare (NYSE:THC) last issued its quarterly earnings data on Thursday, April 30th. The company reported $4.82 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.21 by $0.61. Tenet Healthcare had a return on equity of 25.55% and a net margin of 7.94%.The firm had revenue of $5.37 billion during the quarter, compared to the consensus estimate of $5.39 billion. During the same quarter in the previous year, the company posted $4.36 EPS. The business’s revenue for the quarter was up 2.6% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. On average, sell-side analysts forecast that Tenet Healthcare Corporation will post 17.61 EPS for the current fiscal year.

Tenet Healthcare Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.